<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>E药经理人 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-09T20:30:45+08:00</updated>
  <subtitle>我们致力于成为医药行业意见领袖平台，我们记录和观察医药重大商业事件，展现这个行业的复杂和冲突，提供最前线的思想火花。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>众多十亿美元级品种入选四批集采，这些药企涉及产品最多！这几个热门品种却没纳入！</title>
    <updated>2020-12-09T17:48:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/fB7l4_Et5g4IefNsUHsx7w</id>
    <link href="https://mp.weixin.qq.com/s/fB7l4_Et5g4IefNsUHsx7w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球问世30年，这项革命性分子互作技术为什么能成为行业金标准？</title>
    <updated>2020-12-09T17:48:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/6YnxY3BkvHov-bfIXa9-6w</id>
    <link href="https://mp.weixin.qq.com/s/6YnxY3BkvHov-bfIXa9-6w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首个用于治疗系统性红斑狼疮的靶向生物制剂贝利尤单抗获批儿童适应症，惠及五岁及以上患儿</title>
    <updated>2020-12-09T17:48:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/Hlx9sAG5U5QQ3UkTjIqoGQ</id>
    <link href="https://mp.weixin.qq.com/s/Hlx9sAG5U5QQ3UkTjIqoGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>独家专访复宏汉霖CEO张文杰：复宏汉霖进入发展第二阶段，要实现生物类似药和创新药双领导地位</title>
    <updated>2020-12-08T20:09:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/91guZL-GiHUE7zFCwpwIKQ</id>
    <link href="https://mp.weixin.qq.com/s/91guZL-GiHUE7zFCwpwIKQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>他说：一般一年两次集采！500个品种动态调整，量大、竞争激烈优先纳入？</title>
    <updated>2020-12-08T20:09:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/9AkvXPoAE6oJCAdiD3y7_Q</id>
    <link href="https://mp.weixin.qq.com/s/9AkvXPoAE6oJCAdiD3y7_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！恒瑞医药卡瑞利珠单抗+苹果酸法米替尼联合疗法被纳入拟突破性治疗品种公示</title>
    <updated>2020-12-08T20:09:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/o9EAbcKqdKVwEOfSr93cyg</id>
    <link href="https://mp.weixin.qq.com/s/o9EAbcKqdKVwEOfSr93cyg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【投资人观点】京东健康首日市值超阿里健康，怎么看医药电商估值的高与低？</title>
    <updated>2020-12-08T20:09:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/feF_tI41Ilj9zs724e6vew</id>
    <link href="https://mp.weixin.qq.com/s/feF_tI41Ilj9zs724e6vew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>30年医药产业资本浮沉，沃森生物有点“嫩”！</title>
    <updated>2020-12-07T21:20:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/z5GRaIwkLCzDQ_UDvRTzmA</id>
    <link href="https://mp.weixin.qq.com/s/z5GRaIwkLCzDQ_UDvRTzmA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>被高瓴称为“新冠疫苗黑马”，年产量可达10亿剂，获超20亿元国际资助，这家创新药企凭什么？</title>
    <updated>2020-12-07T21:20:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/GW43Qfz9ChBIhmfNnKsLFg</id>
    <link href="https://mp.weixin.qq.com/s/GW43Qfz9ChBIhmfNnKsLFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Ⅱ期临床成功率被提升2倍！辉瑞如何做到的？</title>
    <updated>2020-12-07T21:20:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/Pr1ddCAdgjJTH09PXqBtxA</id>
    <link href="https://mp.weixin.qq.com/s/Pr1ddCAdgjJTH09PXqBtxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞员工评价孙飘扬：他真的是喜欢研发！</title>
    <updated>2020-12-06T18:34:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/-eNf6L-57mzQUUILWAEDdA</id>
    <link href="https://mp.weixin.qq.com/s/-eNf6L-57mzQUUILWAEDdA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>不选择license in，看璎黎药业的从0到1之路</title>
    <updated>2020-12-06T18:34:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/Fq44bY_k3C2rRpEM5fXHxQ</id>
    <link href="https://mp.weixin.qq.com/s/Fq44bY_k3C2rRpEM5fXHxQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一笔刷历史新高的license out背后，biotech如何跑步进入2.0</title>
    <updated>2020-12-05T19:27:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/S22hgitS2j7flKBH3fnBPg</id>
    <link href="https://mp.weixin.qq.com/s/S22hgitS2j7flKBH3fnBPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>老药新用，滚动开发！解密亚虹研发策略，为什么他能做成？</title>
    <updated>2020-12-05T19:27:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/snrEaEfMSXexlFpzGNe5qQ</id>
    <link href="https://mp.weixin.qq.com/s/snrEaEfMSXexlFpzGNe5qQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>研发费用平均增长45% ，A+H疫苗第一股康希诺的创新逻辑</title>
    <updated>2020-12-05T19:27:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/sbovFQGkXG31lQE2f2gglQ</id>
    <link href="https://mp.weixin.qq.com/s/sbovFQGkXG31lQE2f2gglQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国医药产业社会责任公益线上展——一群人的力量和坚持可以改变历史</title>
    <updated>2020-12-05T19:27:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/kY7j2FHTcpiCYF-aeC70YA</id>
    <link href="https://mp.weixin.qq.com/s/kY7j2FHTcpiCYF-aeC70YA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>4000家药企仅10%有药物警戒团队！GVP出台影响所有MAH！</title>
    <updated>2020-12-04T21:54:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/OZ8BfKsqTpWEq9_ul7xI6g</id>
    <link href="https://mp.weixin.qq.com/s/OZ8BfKsqTpWEq9_ul7xI6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亚盛、再鼎、天演一众Biotech狂揽人才！CRO公司：不要再从我们这挖人了？</title>
    <updated>2020-12-04T21:54:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/8FXq-umPgrtcD6NiILZFQQ</id>
    <link href="https://mp.weixin.qq.com/s/8FXq-umPgrtcD6NiILZFQQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>甘肃215个药品撤废后的思考？是什么原因？会成为常态吗？解在哪儿？</title>
    <updated>2020-12-04T21:54:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/yvep6U4mn8J8jcCV3eDDIA</id>
    <link href="https://mp.weixin.qq.com/s/yvep6U4mn8J8jcCV3eDDIA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中药市值一哥深耕化药！集采重压下，中药企业如何突围？</title>
    <updated>2020-12-03T22:14:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/-n5yiPBTVnsVSKFeSU3boA</id>
    <link href="https://mp.weixin.qq.com/s/-n5yiPBTVnsVSKFeSU3boA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>